Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2022 · Kidney International · 169 citations
https://doi.org/10.1016/j.kint.2022.03.019
M
Masafumi Fukagawa
Tokai University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.2K
Papers
22.2K
Citations
75
h-index
394
i10-index
Masafumi Fukagawa is an academic researcher from Tokai University. The author has contributed to research in topics: Parathyroid Disorders and Treatments & Dialysis and Renal Disease Management & Genetic Syndromes and Imprinting. The author has an h-index of 75, co-authored 1013 publications.
ORCID: 0000-0002-7832-2339Papers by this author
worksRelationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
2018 · American Journal of Kidney Diseases · 91 citations
https://doi.org/10.1053/j.ajkd.2018.08.013
PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
2016 · Scientific Reports · 58 citations
https://doi.org/10.1038/srep19612
2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report
2019 · Kidney International Reports · 56 citations
https://doi.org/10.1016/j.ekir.2019.09.007
New insights into the role of fibroblast growth factor 23 in chronic kidney disease
2010 · Journal of Nephrology · 44 citations
https://doi.org/10.1093/joneph/23.6.619
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study
2019 · Scientific Reports · 36 citations
https://doi.org/10.1038/s41598-019-45335-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat